Repros Therapeutics Inc (NASDAQ:RPRX) riding on a testosterone Androxal high 76.34% - ABBV, LLY, AUXL
Repros riding on a testosterone Androxal high 76.34% Northern, WI 04/01/2013 (avauncer) - The Repros Therapeutics Inc (NASDAQ:RPRX) (Current: $16.10, Up by 76.34%) ‘s testosterone stimulating drug Androxal was under trail and the company has announced very positive results....
Posted On 01 Apr 2013